Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer

Clinical trial NCT00377559 · COMPLETED

Trial details

NCT number: NCT00377559
Sponsor: Catharina Ziekenhuis Eindhoven
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Neoplasm Metastasis

Start date: 2006-05-01
Primary completion: 2009-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.